October's top STAT+ stories: How Moderna unraveled & more 👀

Take advantage of 25% off an annual STAT+ subscription to dive into these stories.

My Account    STAT+ Check out October's top stories. If you like what you see, join the STAT+ community today – and enjoy 25% off your first year with code LOYAL25. Mike Reddy for STAT 1   How Moderna, the company that helped save the world, unraveled By Jason Mast Molly Ferguson for STAT 2   All of a sudden, dementia treatment is becoming very exciting By Jason Karlawish Molly Ferguson/STAT 3   For Intellia Therapeutics, CRISPR drug's safety concern is an existential threat By Adam Feuerstein 25% off STAT+ Get 25% off your first year of STAT+ with discount code LOYAL25. SUBSCRIBE NOW More Top Stories 4   Under Vinay Prasad, employees at a key FDA center fear speaking out, look for the exits By Lizzy Lawrence 5   The limits of FDA flexibility are tested as a controversial Biohaven drug decision nears By Adam Feuerstein 6   Inside FDA, career staffers describe how political pressure is influencing their work By Lizzy Lawrence 7   Time is running out for Anavex and its treatment for Alzheimer's disease By Adam Feuerstein 8   Trump cuts have decimated the federal addiction and mental health agency By O. Rose Broderick and Lev Facher 9   How North Carolina built manufacturing boomtowns for biotech By Allison DeAngelis 10   How the first nine drug companies won priority review vouchers from Marty Makary's FDA By Lizzy Lawrence read more STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails Update Newsletter Preferences • Contact Us • Advertise with Us